Impact of COVID-19 Pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome.

Background: Individuals recovering from COVID-19 infection have reported experiencing symptoms of postural orthostatic tachycardia syndrome (POTS). These observations have raised concerns about COVID-19 as a significant precipitating factor in the development of post-viral POTS. Given the increasing number of POTS cases reported after COVID-19, we sought to examine the baseline characteristics of POTS patients before and after COVID-19.

Impact of percutaneous left atrial appendage occlusion on the severity of ischemic stroke.

Background: Percutaneous left atrial appendage occlusion (pLAAO) presents an alternative to anticoagulation (AC) for stroke prophylaxis in atrial fibrillation (Afib) patients with high bleeding risk. pLAAO was associated with lower rates of disabling stroke which was mainly attributed to the reduction of hemorrhagic stroke (HS). Little is known about the impact of pLAAO on the severity of ischemic strokes which we sought to study.

Predictive Modeling of Osteoarthritis Using Biochemical Markers: A Cross-Sectional Analysis.

Introduction: Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by cartilage deterioration, joint pain, and reduced mobility. This study aimed to quantify the association between specific biochemical markers and OA and to develop a predictive model for assessing OA risk based on these markers.

Materials And Methods: A total of 200 participants (mean age: 55.

Attachment Wear in Different Clear Aligner Therapy: A Comparative Study.

Background: Because of its ease and visual attractiveness, clear aligner therapy has grown in popularity as an orthodontic treatment option. On the other hand, the results of therapy may be impacted by attachment wear. Comparing attachment wear in three distinct clear aligner systems-System A, System B, and System C-was the goal of this investigation.

Amiodarone and β-blocker combination therapy versus β-blocker monotherapy for ICD shock prevention: A meta-analysis.

While implantable cardioverter-defibrillator (ICD) shocks are a lifesaving therapy, they can negatively affect the patient's quality of life. Amiodarone is commonly combined with β-blockers (BB) in ICD recipients. However, this combination therapy's efficacy in preventing shocks compared to standard BB monotherapy is not well studied.